Burdet C, Grall N, Linard M, Bridier-Nahmias A, Benhayoun M, Bourabha K
Antimicrob Agents Chemother. 2019; 63(6).
PMID: 30936104
PMC: 6535507.
DOI: 10.1128/AAC.02244-18.
Medaney F, Dimitriu T, Ellis R, Raymond B
ISME J. 2015; 10(3):778-87.
PMID: 26505830
PMC: 4817691.
DOI: 10.1038/ismej.2015.154.
Sharma S, Srivastava A
J Vet Sci. 2006; 7(2):119-22.
PMID: 16645334
PMC: 3242101.
DOI: 10.4142/jvs.2006.7.2.119.
Sharma S, Srivastava A
Vet Res Commun. 1994; 18(4):313-8.
PMID: 7831762
DOI: 10.1007/BF01839199.
Neu H, Labthavikul P
Antimicrob Agents Chemother. 1983; 24(3):313-20.
PMID: 6605718
PMC: 185318.
DOI: 10.1128/AAC.24.3.313.
Cefsulodin sodium therapy in cystic fibrosis patients.
Cabezudo I, Thompson R, Selden R, Guenthner S, Wenzel R
Antimicrob Agents Chemother. 1984; 25(1):4-6.
PMID: 6422844
PMC: 185422.
DOI: 10.1128/AAC.25.1.4.
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
Richards D, Heel R, Brogden R, Speight T, Avery G
Drugs. 1984; 27(6):469-527.
PMID: 6329638
DOI: 10.2165/00003495-198427060-00001.
Production of hypoprothrombinemia by moxalactam and 1-methyl-5-thiotetrazole in rats.
Lipsky J, Lewis J, NOVICK Jr W
Antimicrob Agents Chemother. 1984; 25(3):380-1.
PMID: 6326667
PMC: 185524.
DOI: 10.1128/AAC.25.3.380.
The Antibacterial activity in vitro and beta-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides.
Seibert G, Limbert M, Winkler I, Dick T
Infection. 1983; 11(5):275-9.
PMID: 6315595
DOI: 10.1007/BF01641262.
In vitro activity and beta-lactamase stability of cefodizime, an aminothiazolyl iminomethoxy cephalosporin.
Scully B, Jules K, Neu H
Antimicrob Agents Chemother. 1983; 23(6):907-13.
PMID: 6311090
PMC: 185001.
DOI: 10.1128/AAC.23.6.907.
Chemotherapeutic properties of the new cephalosporin antibiotic HR810 in laboratory animals.
Klesel N, Limbert M, Schrinner E, Seeger K, Seibert G, Winkler I
Infection. 1984; 12(4):286-92.
PMID: 6092278
DOI: 10.1007/BF01645963.
Pharmacokinetics and safety of ceftriaxone in the neonate.
Mulhall A, DE LOUVOIS J, James J
Eur J Pediatr. 1985; 144(4):379-82.
PMID: 4076254
DOI: 10.1007/BF00441782.
The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.
Neu H, Chin N, Labthavikul P
Infection. 1985; 13(3):146-55.
PMID: 3928497
DOI: 10.1007/BF01642876.
Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.
Nichols R, Wikler M, McDevitt J, Lentnek A, Hosutt J
Antimicrob Agents Chemother. 1987; 31(2):281-5.
PMID: 3471181
PMC: 174706.
DOI: 10.1128/AAC.31.2.281.
Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients.
SCHWARTZ J, Jauregui L, Bachmann K, Martin M, Reitberg D
Antimicrob Agents Chemother. 1988; 32(5):730-5.
PMID: 3395103
PMC: 172261.
DOI: 10.1128/AAC.32.5.730.
Pharmacokinetic properties of the cephalosporins.
Bergan T
Drugs. 1987; 34 Suppl 2:89-104.
PMID: 3319507
DOI: 10.2165/00003495-198700342-00008.
Bile levels of imipenem in patients with T-drain following the administration of imipenem/cilastatin.
Mayer M, Tophof C, Opferkuch W
Infection. 1988; 16(4):225-8.
PMID: 3182087
DOI: 10.1007/BF01650757.
Cephalosporins increase the renal clearance of methotrexate and 7-hydroxymethotrexate in rabbits.
Iven H, Brasch H
Cancer Chemother Pharmacol. 1990; 26(2):139-43.
PMID: 2189590
DOI: 10.1007/BF02897260.
Pharmacological properties of cephalosporins.
CHRIST W
Infection. 1991; 19 Suppl 5:S244-52.
PMID: 1783440
DOI: 10.1007/BF01645535.
